000098426 001__ 98426 000098426 005__ 20210128133202.0 000098426 0248_ $$2sideral$$a122188 000098426 037__ $$aART-2019-122188 000098426 041__ $$aeng 000098426 100__ $$0(orcid)0000-0001-5632-0351$$aMarron, S.E. 000098426 245__ $$aThe psychological burden of skin diseases in Spain 000098426 260__ $$c2019 000098426 5060_ $$aAccess copy available to the general public$$fUnrestricted 000098426 5203_ $$aP16 Objective: Atopic dermatitis affects patients’ quality of life (QoL) in many ways. It is important to analyze the impact that the disease produces in order to better define the healthcare needs of adult patients with atopic dermatitis. Patients and Methods: 14 adult patients with atopic dermatitis were interviewed. The qualitative interviews were semi-structured and supported by a simple script, which allowed a complete and flexible interview. Results: Six affected areas of the patient’s life with atopic dermatitis were identified: economic, work-related, personal, psychosocial, clinical and relational. It is emphasized that atopic dermatitis has a great psychosocial impact on the adult patient, since it alters interpersonal relationships, generates rejection, stigmatization and social isolation, limits the patient in various areas and activities of their daily life or alters sleep, among others. The visible aspect, the itching-scratching cycle, the lack of awareness and ignorance of the disease, the lack of a definitive solution among the treatments and the side effects of some of them are of great concern. Conclusions: The QoL of the patients with atopic dermatitis is negatively affected and a holistic multidisciplinary intervention is necessary in order to mitigate the negative impact of the disease. 000098426 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/ 000098426 590__ $$a4.016$$b2019 000098426 591__ $$aDERMATOLOGY$$b7 / 68 = 0.103$$c2019$$dQ1$$eT1 000098426 592__ $$a1.01$$b2019 000098426 593__ $$aMedicine (miscellaneous)$$c2019$$dQ1 000098426 593__ $$aDermatology$$c2019$$dQ1 000098426 655_4 $$ainfo:eu-repo/semantics/conferenceObject$$vinfo:eu-repo/semantics/publishedVersion 000098426 700__ $$aCerro-Muñoz, P.A. 000098426 700__ $$aPalma-Ruiz, A.M. 000098426 700__ $$0(orcid)0000-0003-0365-4301$$aGarcia-Felipe, R.$$uUniversidad de Zaragoza 000098426 700__ $$0(orcid)0000-0002-1870-8846$$aSimal-Gil, E.$$uUniversidad de Zaragoza 000098426 700__ $$aSanchez-Hernandez, M. 000098426 700__ $$aMartin-Marco, R. 000098426 700__ $$aBaldellou-Lasierra, R. 000098426 700__ $$0(orcid)0000-0001-8034-3617$$aGilaberte-Calzada, Y.$$uUniversidad de Zaragoza 000098426 700__ $$0(orcid)0000-0001-5073-4465$$aBoira-Sarto, S.$$uUniversidad de Zaragoza 000098426 700__ $$0(orcid)0000-0003-1917-6906$$aTomas-Aragones, L.$$uUniversidad de Zaragoza 000098426 7102_ $$14009$$2735$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicolog.Evolut.Educac 000098426 7102_ $$14009$$2813$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Trabajo Social y Serv.Soc 000098426 7102_ $$11007$$2183$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cÁrea Dermatología 000098426 773__ $$g99, 8 (2019), 752-752$$pActa derm.-venereol.$$tACTA DERMATO-VENEREOLOGICA$$x0001-5555 000098426 85641 $$uhttps://www.medicaljournals.se/acta/download/10.2340/00015555-3228/$$zTexto completo de la revista 000098426 8564_ $$s88580$$uhttps://zaguan.unizar.es/record/98426/files/texto_completo.pdf$$yVersión publicada 000098426 8564_ $$s4176705$$uhttps://zaguan.unizar.es/record/98426/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000098426 909CO $$ooai:zaguan.unizar.es:98426$$particulos$$pdriver 000098426 951__ $$a2021-01-28-12:42:52 000098426 980__ $$aARTICLE